Business Context and Reporting Period
Company: The Macerich Company (MAC)
Filing Type: Form 8-K (Current Report)
Reporting Date: June 17, 2026
Event Date: June 15, 2026 (Underwriting Agreement); June 17, 2026 (Offering Close)
The Company entered into an underwriting agreement and forward sale agreements to offer and sell shares of its common stock. The transaction involves a forward sale structure where the Company will not receive immediate proceeds but expects to settle physically by June 16, 2027.
Key Financial Metrics and Transaction Details
- Shares Offered: 14,000,000 shares of Common Stock.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 2,100,000 shares.
- Forward Price: $23.12325 per share (subject to adjustments).
- Proceeds Timing: The Company will not initially receive proceeds. Proceeds are expected upon physical settlement no later than June 16, 2027.
- Settlement Method: Expected physical delivery of shares for cash; cash or net share settlement is also possible.
- Use of Proceeds: Net proceeds will be contributed to The Macerich Partnership, L.P. to fund future acquisitions and general corporate purposes.
Material Changes and Unusual Items
This filing reports a significant capital market event rather than a change in operating performance. The material change is the execution of a forward sale agreement, which creates a future obligation to deliver shares and receive cash, distinct from a traditional immediate equity offering.
Unusual Item: The transaction structure involves "Forward Sellers" borrowing shares to sell to underwriters, with the Company agreeing to settle the obligation in the future. This defers the receipt of capital and the dilution impact until the settlement date.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use the net proceeds for future acquisition opportunities and general corporate purposes. Pending use, funds may be invested in short-term, interest-bearing deposit accounts.
Risks and Contingencies:
- Settlement Risk: The Company may elect to cash settle or net share settle, in which case it may not receive proceeds and could owe cash or shares to Forward Purchasers.
- Termination: Forward Sale Agreements are subject to early termination or settlement under certain circumstances.
- Price Adjustments: The forward price is subject to adjustments pursuant to the agreement terms.
Investor Verification Checklist
- Verify the final settlement date and method (physical vs. cash/net) once the settlement period approaches (by June 16, 2027).
- Confirm whether the 30-day over-allotment option for 2,100,000 additional shares is exercised by the Underwriters.
- Monitor the Company's capital allocation strategy to ensure proceeds are deployed as stated for acquisitions or general purposes.
- Review the specific adjustment mechanisms in the Forward Sale Agreements that could alter the effective price per share.